The success of Viagra initially fueled a surge for pharma, nevertheless recent shifts present a murky scenario for investors. Generic alternatives are reducing earnings, and ongoing litigation add additional difficulty https://bushrawjwh352815.dbblog.net/14488780/viagra-and-pharma-a-volatile-play